Author:
Cannon S.,Williams M.,Gunning A. C.,Wright C. F.
Abstract
ABSTRACTBackgroundThe use ofin silicopathogenicity predictions as evidence when interpreting genetic variants is widely accepted as part of standard variant classification guidelines. Although numerous algorithms have been developed and evaluated for classifying missense variants, in-frame insertions/deletions (indels) have been much less well studied.MethodsWe created a dataset of 3964 small (<100bp) indels predicted to result in in-frame amino acid insertions or deletions using data from gnomAD v3.1 (minor allele frequency of 1-5%), ClinVar and the Deciphering Developmental Disorders (DDD) study. We used this dataset to evaluate the performance of nine pathogenicity predictor tools: CADD, CAPICE, FATHMM-indel, MutPred-Indel, MutationTaster2 PROVEAN, SIFT-indel, VEST-indel and VVP.ResultsOur dataset consisted of 2224 benign/likely benign and 1740 pathogenic/likely pathogenic variants from gnomAD (n=809), ClinVar (n=2882) and, DDD (n=273). We were able to generate scores across all tools for 91% of the variants, with areas under the ROC curve (AUC) of 0.81-0.96 based on the published recommended thresholds. To avoid biases caused by inclusion of our dataset in the tools’ training data, we also evaluated just DDD variants not present in either gnomAD or ClinVar (70 pathogenic and 81 benign). Using this subset, the AUC of all tools decreased substantially to 0.64-0.87. Overall, VEST-indel performed best, with AUCs of 0.93 (full dataset) and 0.87 (DDD subset).ConclusionsAlgorithms designed for predicting the pathogenicity of in-frame indels perform well enough to aid clinical variant classification in a similar manner to missense prediction tools.
Publisher
Cold Spring Harbor Laboratory
Reference37 articles.
1. Toward Clinical Implementation of Next-Generation Sequencing-Based Genetic Testing in Rare Diseases: Where Are We?
2. Kanzi AM , San JE , Chimukangara B , Wilkinson E , Fish M , Ramsuran V , et al. Next Generation Sequencing and Bioinformatics Analysis of Family Genetic Inheritance. Frontiers in Genetics. 2020;11.
3. Gudmundsson S , Singer-Berk M , Watts NA , Phu W , Goodrich JK , Solomonson M , et al. Variant interpretation using population databases: Lessons from gnomAD. Human Mutation. 2021;. 4.
4. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
5. Ellard S , Baple EL , Callaway A , Berry I , Forrester N , Turnbull C , et al. ACGS Best Practice Guidelines for Variant Classification in Rare Disease 2020: ACGS; 2020 [Available from: https://www.acgs.uk.com/media/11631/uk-practice-guidelines-for-variant-classification-v4-01-2020.pdf.